BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT05393466 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05393466
Sponsor: Xcovery Holdings, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Carcinoma

Start date: 2026-07-01
Primary completion: 2028-01-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.